Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2001-08-17
2002-12-31
Solola, T. A. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
06500966
ABSTRACT:
TECHNICAL FIELD
The present invention relates to a process for the preparation of taxanes from 10-deacetylbaccatin III.
The present invention relates to a process for the preparation of taxanes from 10-deacetylbaccatin III.
BACKGROUND OF THE INVENTION
Paclitaxel is a known antitumor drug with taxan structure, whose industrial preparation is particularly complex.
Paclitaxel was first isolated by extraction from the trunk barks of
Taxus brevifolia
, and it is at present synthesized starting from 10-deacetylbaccatin III, an intermediate present in the leaves of different species of taxus, particularly in those of
Taxus baccata
L., thereby overcoming the environmental problems connected with the availability of bark of
T. brevifolia.
A number of synthetic methods are reported in literature: U.S. Pat. No. Re. 34,277 (reissue of U.S. Pat. No. 4,924,011) discloses the. semi-synthesis of Paclitaxel starting from 10-deacetylbaccatin III protected at the C-7 hydroxyl group with a trialkylsilyl group, in particular triethylsilyl, and at the 10-position with an acetyl group. In WO 98/08832, the protection of the C-7 hydroxyl group is carried out using a trichloroacetyl group. The thus protected baccatin III derivative is reacted with acetyl bromide and, subsequently, with the suitable phenylisoserine derivative to obtain Paclitaxel, following deprotection of the hydroxyl groups at 7 and 2′ and benzoylation of the amine.
In WO 93/06094, Paclitaxel is prepared by reacting a beta-lactam-type compound with 7-triethylsilyl-baccatin III. The desired product is obtained by deprotection in acid medium.
In U.S. Pat. No. 5,476,954, the synthesis of Paclitaxel is carried out starting from 10-deacetylbaccatin III, protecting the C-7 hydroxyl with 2,2,2-trichloroethoxycarbonyl(Troc) and the C-10 hydroxyl with Troc or with an acetyl group.
It is therefore evident that the critical step for the synthesis of Paclitaxel is the selective esterification at C-7 with a group easily and selectively removable. Until now, 7-triethylsilyl-deacetylbaccatin III has been considered the key intermediate. The yield reported for the derivatization of 10-deacetylbaccatin III to 7-triethylsilyl-10-deacetylbaccatin III is about 85%, using 5 to 20 mols of silylating agent. The yield of the subsequent acetylation to give 7-triethylsilylbaccatin III is also about 85%.
U.S. Pat. No. 5,621,121 and U.S. Pat. No. 5,637,723 disclose the synthesis of taxanes, including Paclitaxel, by reacting suitably protected baccatin III or 10-deacetylbaccatin III with oxazolidine-5-carboxylic acids bearing at the 2-position a phenyl group substituted with alkoxy groups (U.S. Pat. No. 5,621,121) or with trihaloalkyl groups, in particular trichloromethyl (U.S. Pat. No. 5,637,723), followed by deprotection by opening of the oxazolidine ring.
The protective groups considered particularly suitable comprise silyl, 2,2,2-trichloroethoxycarbonyl or 2-(2(trichloromethyl)propoxy)carbonyl groups.
Substantially the same methods can also be used for the preparation of Docetaxel, another known taxan derivative widely used in clinics.
It has now been found a process for the preparation of taxanes, in particular Paclitaxel and Docetaxel, which attains higher yields than the known methods.
SUMMARY OF THE INVENTION
It has now been found a process for the preparation of taxanes, in particular Paclitaxel and Docetaxel, which attains a higher yield than known methods.
The process of the invention, shown in the following Scheme, comprises:
a) simultaneous protection of the hydroxyl groups at the 7- and 10-positions of 10-deacetylbaccatin III with trichloroacetyl groups.
b) subsequent esterification of the hydroxyl at the 13-position by reaction with a compound of formula (VII):
wherein R is tert.butoxycarbonyl, benzoyl or the residue of a straight or branched aliphatic acid and R
1
is phenyl or a straight or branched alkyl or alkenyl;
c) removal of the trichloroacetic protective groups;
d) optional selective acetylation of the hydroxyl at the 10-position, for those compounds in which R
2
is acetyl;
e) acid hydrolysis of the oxazolidine ring.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
The process of the invention differs from those of the prior art in the that the reaction sequence used provides a simpler route than those processes cited above and a remarkable improvement in the obtained yields.
The process of the invention differs from those of the prior art in that the reaction sequence used provides a simpler route than the known processes cited above and a remarkable improvement in the obtained yields.
Step a) is conventionally effected with trichloroacetic anhydride in suitable solvents and in the presence of bases such as pyridine, triethylamine and the like.
The esterification with the oxazolidine-5-carboxylic acid derivative is carried out in the presence of a condensing agent such as dicyclohexylcarbodiimide or other known reagents, in an anhydrous organic solvent, preferably aliphatic, aromatic or chlorinated hydrocarbons, at temperatures ranging from room temperature to the boiling temperature of the solvent.
The resulting oxazolidine ester is then deprotected by removing the 7- and 10-trichloroacetyl groups by treatment with NH
4
OH/NH
4
Cl in aliphatic alcohols, preferably methanol.
The selective acetylation of the hydroxyl at the 10-position is carried out with acetic anhydride in the presence of cerium III, scandium or ytterbium salts, in a solvent such as tetrahydrofuran, dichloromethane, ethyl acetate, at temperatures ranging from 5 to 40° C.
The treatment with organic or inorganic acids in solvents such as methanol, ethanol, tetrahydrofuran, at temperatures ranging from about −2 to +2° C., yields the desired taxane derivatives. The use of formic acid in tetrahydrofuran at a temperature of 0° C. is particularly preferred.
The oxazolidine intermediates are known or can be prepared with known methods, by reaction of an isoserine ester with 4-methoxy-benzaldehyde.
The choice of anisic aldehyde proved to be particularly important for the formation of the oxazolidine, in that oxazolidine acid, contrary to the methods described in U.S. Pat. Nos. 5,621,121, 5,637,723 (Rhône-Poulenc Rorer), and in U.S. Pat. No. 5,821,363 (UpJohn), can easily be crystallized and adjusted to a 95:5 isomer ratio, which is extremely useful and advantageous for the subsequent step. Furthermore, the oxazolidine carboxylic acid obtainable with anisic aldehyde is particularly stable during the deprotection of the trichloroacetic ester and the subsequent acetylation step. In these conditions, 2,4-dimethoxybenzaldehyde used in U.S. Pat. No. 5,821,363 or chloral or p-trichloromethyl-benzaldehyde as described in U.S. Pat. Nos. 5,621,121 and 5,637,723 (Rhône-Poulenc Rorer) are not sufficiently stable.
The process of the invention, in addition to Paclitaxel (R=benzoyl, R
1
=phenyl) and Docetaxel (R=tert.butoxycarbonyl, R
1
=phenyl), also provides other taxane derivatives efficiently and conveniently.
The compounds of formula IV have never been described before and are therefore a further object of the invention, as intermediates useful for the synthesis of taxane derivatives.
The following Examples illustrate the invention in greater detail.
REFERENCES:
patent: RE34277 (1993-06-01), Denis et al.
patent: 5476954 (1995-12-01), Bourzat et al.
patent: 5621121 (1997-04-01), Commercon et al.
patent: 5637723 (1997-06-01), Commercon et al.
patent: 6130336 (2000-10-01), Kim et al.
patent: 6147234 (2000-11-01), Holton et al.
Indena S.p.A.
Pennie & Edmonds LLP
Solola T. A.
LandOfFree
Process for the preparation of taxanes from... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of taxanes from..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of taxanes from... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2954495